For years, cell and gene therapies were mainly associated with rare and orphan diseases, those that impact small patient groups and lack effective treatment options. However, recent developments in ...

Please provide your email address to receive an email when new articles are posted on . “In addition to patient-reported outcome measures (PROMs), an emerging concept in evaluating the treatment ...